NCT03892018View on ClinicalTrials.gov

The Effect of Food on the Pharmacokinetics of Paclitaxel Administered Orally as Oraxol

PHASE1TerminatedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

August 5, 2019

Primary Completion Date

May 12, 2023

Study Completion Date

May 12, 2023

Conditions
Solid Tumor, Adult
Interventions
DRUG

Oraxol

Oraxol will be supplied as paclitaxel capsules and HM30181AK-US tablets.

Trial Locations (3)

G12 0YN

The Beatson West of Scotland Cancer Care Centre, Glasgow

M20 4BX

The Christie NHS Foundation Trust, Manchester

NE2 4HH

The Northern Institute for Cancer Care, Newcastle upon Tyne

Sponsors

Lead Sponsor

Athenex, Inc.
All Listed Sponsors
lead

Athenex, Inc.

INDUSTRY